A concerning trend is unfolding across Texas: a dramatic surge in whooping cough cases, a highly contagious illness that poses a serious threat, particularly to the most vulnerable.
Health officials have reported over 3,500 cases of pertussis – commonly known as whooping cough – through October, nearly quadrupling the number seen at this point last year. This marks the second consecutive year of significant increases, prompting a renewed health alert for the state.
The illness begins deceptively, mimicking a common cold with a runny nose and mild cough. However, this initial phase quickly escalates into violent, uncontrollable coughing fits that can last for weeks.
These fits are so severe they often culminate in a distinctive, high-pitched “whoop” as the individual struggles to regain breath. The disease progresses through stages, starting with cold-like symptoms, then intense coughing, and finally, a slow recovery.
The greatest danger lies with infants under one year old. They are far more likely to require hospitalization and face life-threatening complications, especially if their immune systems are weakened or they haven’t been vaccinated.
Alarmingly, babies may not exhibit the characteristic “whoop” at all. Instead, they can experience dangerous pauses in breathing or significant difficulty breathing, making early detection crucial.
While infants are most at risk, teenagers and adults are also susceptible, often due to waning immunity from childhood vaccinations. Their symptoms tend to be milder, but they can still unknowingly spread the infection to those more vulnerable.
Health leaders emphasize the critical importance of staying current with pertussis vaccinations for all ages. Protection from the vaccine diminishes over time, leaving individuals susceptible to infection.
A Tdap vaccine is strongly recommended for pregnant women during each pregnancy, ideally between 27 and 36 weeks. This provides vital antibodies to the newborn, offering crucial early protection.
Those who will be in close contact with infants should also receive a Tdap booster at least two weeks before potential exposure. This creates a protective barrier around the baby, minimizing the risk of transmission.
Clinicians are urged to consider pertussis in any patient presenting with consistent symptoms and to initiate testing. Rapid PCR tests are readily available and can quickly confirm a diagnosis, allowing for prompt treatment, even based on strong clinical suspicion.
